Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.54 |
| ▸ | ZDHHC2 | Q9UIJ5 | 3/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1903761 | 1.00 | ALDH1A1 (0.66) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR | |
| SCHEMBL1395633 | 1.00 | ALDH1A1 (0.66) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR | |
| SCHEMBL9618288 | 0.94 | ALDH1A1 (0.64) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR | |
| SCHEMBL4171758 | 0.94 | ALDH1A1 (0.64) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR | |
| SCHEMBL24687428 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR | |
| SCHEMBL5756799 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR | |
| SCHEMBL1289327 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR | |
| SCHEMBL444527 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR | |
| SCHEMBL5362501 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR | |
| SCHEMBL9364410 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TAAR1ZDHHC2ZDHHC20EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612529-B2 | Ethylene/alpha-olefin copolymer composition and application thereof | MITSUI CHEMICALS, INC. (JP) | 2026-04-28 | — | — | US | disclosed |
| US-20260103836-A1 | WATER DISPERSION, CARBON FIBER BUNDLE, AND UNIDIRECTIONAL MATERIAL | MITSUI CHEMICALS, INC. (JP) | 2026-04-16 | — | — | US | disclosed |
| US-20260085184-A1 | ADHESIVE RESIN COMPOSITION | KURARAY CO., LTD. (JP) | 2026-03-26 | — | — | US | disclosed |
| EP-4636034-A1 | ADHESIVE RESIN COMPOSITION | Kuraray Co., Ltd. (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-20250277109-A1 | RESIN COMPOSITION AND MULTILAYER LAMINATED FILM | MITSUI CHEMICALS, INC. (JP) | 2025-09-04 | — | — | US | disclosed |
| US-20250250427-A1 | ARTICLE, CROSSLINKED THERMOPLASTIC ELASTOMER COMPOSITION, AND PRODUCING METHOD THEREOF | MCPP INNOVATION LLC (JP) | 2025-08-07 | — | — | US | disclosed |
| EP-4596785-A1 | WATER DISPERSION, CARBON FIBER BUNDLE, AND UNIDIRECTIONAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-20250197621-A1 | THERMOPLASTIC RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2025-06-19 | — | — | US | disclosed |
| CN-120092116-A | Aqueous dispersion, carbon fiber bundle, and unidirectional material | 三井化学株式会社 | 2025-06-03 | — | — | CN | disclosed |
| WO-2025047974-A1 | BATTERY PACK AND USE OF ADHESIVE SHEET | 三菱ケミカル株式会社 | 2025-03-06 | — | — | WO | disclosed |
| CN-115003757-A | Polyamide composition | 三井化学株式会社 | 2022-09-02 | — | — | CN | disclosed |
| EP-4043520-A1 | ETHYLENE-OLEFIN COPOLYMER COMPOSITION AND USE OF SAME | Mitsui Chemicals, Inc. (JP) | 2022-08-17 | — | — | EP | disclosed |
| CN-114514277-A | Ethylene-alpha-olefin copolymer composition and use thereof | 三井化学株式会社 | 2022-05-17 | — | — | CN | disclosed |
| EP-3550620-B1 | PIEZOELECTRIC ELEMENT AND MUSICAL INSTRUMENT | YUPO CORP (JP) | 2022-05-04 | — | — | EP | disclosed |
| CN-110214358-B | Energy conversion film and energy conversion element using same | 优泊公司 | 2022-03-22 | — | — | CN | disclosed |
| US-20070196360-A1 | SUCCINIMIDE AND MALEIMIDE DERIVATIVES AND THEIR USE AS TOPOISOMERASE II CATALYTIC INHIBITORS | TOPOTARGET A/S | 2007-08-23 | — | — | US | disclosed |
| EP-1373494-B1 | SUCCINIMIDE AND MALEIMIDE DERIVATIVES AND THEIR USE AS TOPOISOMERASE II CATALYTIC INHIBITORS | TOPOTARGET AS (DK) | 2006-03-01 | — | — | EP | disclosed |
| EP-1373494-A2 | SUCCINIMIDE AND MALEIMIDE DERIVATIVES AND THEIR USE AS TOPOISOMERASE II CATALYTIC INHIBITORS | Topo Target A/S (DK) | 2004-01-02 | — | — | EP | disclosed |
| US-20030032625-A1 | Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors | TOPO TARGET APS (DK) | 2003-02-13 | — | — | US | disclosed |
| WO-2002078679-A2 | SUCCINIMIDE AND MALEIMIDE DERIVATIVES AND THEIR USE AS TOPOISOMERASE II CATALYTIC INHIBITORS | TOPO TARGET APS (DK) | 2002-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032625-A1 | Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors | TOP2A, TOP2B, TOP1 | ALDH1A1 2038/4885TAAR1 4866/4885ZDHHC2 3206/4885 |
| US-12612529-B2 | Ethylene/alpha-olefin copolymer composition and application thereof | ELOVL1, EEF1D, EEF1G | ALDH1A1 815/4885TAAR1 1504/4885ZDHHC2 1623/4885 |
| US-20260103836-A1 | WATER DISPERSION, CARBON FIBER BUNDLE, AND UNIDIRECTIONAL MATERIAL | MACF1, ARCN1, LCP1 | ALDH1A1 1938/4885TAAR1 4131/4885ZDHHC2 4295/4885 |
| US-20260085184-A1 | ADHESIVE RESIN COMPOSITION | COL1A1, ICAM1, COL2A1 | ALDH1A1 529/4885TAAR1 1391/4885ZDHHC2 4053/4885 |
| US-20070196360-A1 | SUCCINIMIDE AND MALEIMIDE DERIVATIVES AND THEIR USE AS TOPOISOMERASE II CATALYTIC INHIBITORS | TOP2A, TOP2B, TOP1 | ALDH1A1 2038/4885TAAR1 4866/4885ZDHHC2 3206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.